Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novus Dental AS is a Norwegian medical technology company specializing in the development and commercialization of innovative biomaterials for dental and orthopedic bone regeneration. The company's flagship product, Novus, is a synthetic bone substitute designed to provide a highly porous scaffold that mimics natural bone architecture to facilitate new bone growth. Based on a proprietary patented process for producing porous calcium phosphate, the material is used in various clinical applications including dental implant site preparation, ridge augmentation, and sinus lifts. Novus Dental aims to provide clinicians with a safe, effective, and easy-to-handle alternative to autografts and allografts in oral and maxillofacial surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novus Dental.